• Cells involved
    • Osteoclasts: degrade bone tissue by secreting collagenase and H+
    • Osteoblasts
      • Build bone tissue by secreting type I collagen
      • Activity assessed by an increase in bone ALP, osteocalcin, and type I procollagen propeptides

Mnemonic

Blasts Build, Clasts Crumble.

Bone remodeling in cortical bone

Pasted image 20240402162925.png

Degradation

  • Osteoclasts organize in a basic multicellular unit (BMU) and excavate a tunnel in the cortical bone.
  • Connective tissue vessels and unmyelinated nerves grow in the tunnel.

Formation

  • Osteoclasts are followed by osteoblasts → deposition of the first osteoid layer in the tunnel
  • Additional osteoblasts follow and deposit osteoid onto the first osteoid layer → osteoblasts of the first layer are walled in → osteoblasts become osteocytes
    • Osteocyte function relies on the presence of gap junctions that connect the cytoplasmic processes between osteocytes. These junctions facilitate cell-to-cell communication, allowing intracellular signals (eg, calcium, cyclic AMP) to propagate to neighboring cells.
  • The deposition process is repeated until the tunnel is almost full → central Haversian canal remains open
  • The innermost (i.e., last) generation of osteoblasts is no longer walled in → cells return to their resting state and form the endosteum

Mineralization: occurs successively

  • Osteoblasts secrete collagen and vesicles into the extracellular matrix.
  • Vesicles contain enzymes (e.g., alkaline phosphatase), which increase local phosphate levels (e.g., by cleavage of pyrophosphate).
  • Calcium-binding molecules in the vesicles most likely serve as a focal point.
  • Initial formation of hydroxyapatite crystals around the focal point in the vesicles
  • Independent growth of the crystals until penetration of the vesicle membrane
  • Release of crystals in the extracellular matrix
  • Growth of crystals in the extracellular matrix and accumulation of collagen fibrils

Regulation of bone remodeling

  • RANK (receptor activator of nuclear factor κB): receptor on osteoclasts and osteoclast precursors, for interaction with osteoblasts
  • RANKL (receptor activator of nuclear factor κB ligand)
    • Membrane-bound protein of osteoblasts that stimulates osteoclasts by interacting with RANK
    • Ensures fusion and differentiation into activated osteoclasts and prevents their apoptosis
  • Hormones
    • PTH effects
      • At low levels: increased bone formation and increased apoptosis of osteoclasts → decreased bone resorption (anabolic effects)
      • At high levels (e.g., primary hyperparathyroidism): activation of osteoclasts → increased bone resorption (catabolic effects) → osteoporosis or osteitis fibrosa cystica
    • Estrogen effects
      • Inhibits apoptosis of osteoblasts, leading to increased bone formation
      • Stimulates apoptosis of osteoclasts, leading to decreased bone resorption
      • Stimulates closure of the epiphyseal plate in puberty
      • Estrogen deficiency (e.g., postmenopausal or after bilateral oophorectomy) leads to increased bone resorption, which can result in osteoporosis.
    • Thyroid hormone
      • In long-standing hyperthyroidism, osteoporosis due to the direct effect of T3 on osteoclastic bone resorption, fractures (in the elderly)